Pulmonary amyloidosis in Sjögren's syndrome: a rare diagnosis for nodular lung lesions.
Lung involvement in Sjögren's syndrome (SS) can affect trachea, bronchus, small airways, pleura and may cause interstitial lung injury. It may also be associated with malignancies, particularly non-Hodgkin's lymphoma, which is a well-recognized complication of this disease. Here we describe the occurrence of localized amyloidosis presenting as pulmonary nodules in a patient with newly diagnosed SS. We highlight this rare occurrence as a diagnostic possibility that should be considered in the evaluation of pulmonary involvement in this disease.
Rodrigues
Kenia
K
Rheumatology Division, Federal University of Santa Catarina, Florianópolis, Brazil.
Neves
Fabricio S
FS
Stoeterau
Karin B L
KB
Werner Castro
Gláucio R
GR
Nobre
Luiz F
LF
Zimmermann
Adriana F
AF
Pereira
Ivânio A
IA
D000682:Amyloid / Q000737:chemistry; D000686:Amyloidosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D004396:Coloring Agents / Q000737:chemistry; D003224:Congo Red / Q000737:chemistry; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008171:Lung Diseases / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
D000682:Amyloid; D018501:Antirheumatic Agents; D004396:Coloring Agents; D005938:Glucocorticoids; D003224:Congo Red; D006886:Hydroxychloroquine; D001379:Azathioprine; D011241:Prednisone